Lexagene Holdings (TSXV:LXG.H) Current Accrued Expense : C$0.25 Mil (As of Nov. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Current Accrued Expense?

Lexagene Holdings's Current Accrued Expense for the quarter that ended in Nov. 2022 was C$0.25 Mil.

Lexagene Holdings's quarterly Current Accrued Expense declined from May. 2022 (C$0.72 Mil) to Aug. 2022 (C$0.34 Mil) and declined from Aug. 2022 (C$0.34 Mil) to Nov. 2022 (C$0.25 Mil).

Lexagene Holdings's annual Current Accrued Expense increased from Feb. 2020 (C$0.29 Mil) to Feb. 2021 (C$0.91 Mil) but then declined from Feb. 2021 (C$0.91 Mil) to Feb. 2022 (C$0.73 Mil).

Lexagene Holdings Current Accrued Expense Historical Data

The historical data trend for Lexagene Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Current Accrued Expense Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Current Accrued Expense

Get a 7-Day Free Trial

0.32

0.42

0.29

0.91

0.73

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Current Accrued Expense	Get a 7-Day Free Trial															0.43	0.73	0.72	0.34	0.25

Lexagene Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Lexagene Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (TSXV:LXG.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines